Ology Biosciences

Ology Bioservices is a Contract Development and Manufacturing Organization (CDMO) specializing in the rapid development and production of biologics, including vaccines, monoclonal antibodies, and recombinant proteins. Formerly known as Nanotherapeutics, the company operates a state-of-the-art 183,000-square-foot Advanced Development and Manufacturing (ADM) facility in Alachua, Florida, which includes BSL-3 capabilities. The company has a significant history of partnering with the U.S. Department of Defense (DoD) and other government agencies to develop medical countermeasures against infectious diseases and biological threats. In April 2021, Ology Bioservices was acquired by National Resilience, Inc. (Resilience), integrating its specialized biodefense and manufacturing expertise into Resilience's national network.